-
17-year-old advocate shares her NMOSD story to raise awareness
In 2018, when Nell Choi was 9 years old, she began experiencing symptoms that led
-
MDA 2026: ‘Body of evidence for Elevidys continues to grow’
Boys with Duchenne muscular dystrophy (DMD) who received Sarepta Therapeutics’ gene therapy Elevidys (delandistrogene moxeparvovec-rokl)








